Insider · CIK 0001361712
Otello Stampacchia
director
Files at IMA (ImageneBio, Inc.). First filing Jul 30, 2025, latest Jul 30, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$8.0M bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IMA: ImageneBio, Inc.
IMAOct 9, 2026 · close 4.24
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 58Moderate | ImageneBio, Inc. | $8.0M 267,556 shares | +143% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 25, 2025 | IMA ImageneBio, Inc. | MOption exercise Common Stock | +379 | - | - | 379 | Jul 30, 2025 |
| Jul 25, 2025 | IMA ImageneBio, Inc. | POpen-market purchase Common Stockindirect: Omega Fund VI, L.P. | +267,556 | $29.90 | $8.0M | 454,982 | Jul 30, 2025 |
| Jul 25, 2025 | IMA ImageneBio, Inc. | MOption exercise Stock Option (right to buy)derivative | -17,520 | $0.00 | $0 | 0 | Jul 30, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.